Skip to main content

Treatments · the non-prescription lane

CBD and THC in midlife, an honest read, neither sold to you nor scolded out of you.

Cannabis comes up in almost every midlife conversation now — gummies for sleep, CBD for anxiety, the dispensary clerk's confident hot-flash claim. Some of it is real, some is marketing, and the part nobody mentions is the drug interactions. What the evidence supports, what it doesn't, the interactions that matter, and how to bring this up with a doctor without it becoming a lecture.

The five-second version

For pain the evidence is real. For sleep and acute anxiety it's modest. For hot flashes, mood, and libido it's mostly marketing. The interactions with HRT, SSRIs, tamoxifen and blood thinners are the bit that almost nobody mentions at the dispensary, and the bit most worth raising at the appointment.

The basics, plainly

What CBD, THC and full-spectrum actually are

CBD (cannabidiol) is non-intoxicating. It won't get you high, won't show up on most drug tests at typical doses, and is legal in most places where this site is read. The effect at usable doses is subtle, more "edge taken off" than anything dramatic.

THC (tetrahydrocannabinol) is the intoxicating one. It will get you high, it does show up on drug tests, and its legal status varies wildly by country and US state. In midlife, the dose that feels good often drops sharply, what worked at 25 can be too much at 50.

Full-spectrum products contain CBD plus trace THC (under 0.3% in the US, varies elsewhere) plus other cannabinoids and terpenes. Broad-spectrum is similar minus the THC. Isolate is CBD only. The "entourage effect" claim that full-spectrum is meaningfully better is plausible but not well-established in trials.

Your body makes its own cannabinoids, that's the endocannabinoid system, which sits alongside the nervous, immune and endocrine systems and helps regulate sleep, mood, pain and appetite. Estrogen modulates it, which is part of why some midlife symptoms shift around it, and part of why responses to cannabis can change after 40 in ways they didn't at 25.

What the evidence says, by symptom

Honest grades, not hopeful ones

  1. Sleep

    Evidence: Modest

    CBD at higher doses (around 100–300 mg) has a small but real signal for sleep onset and middle-of-the-night waking in non-cancer populations. THC shortens sleep latency but reduces REM, which most people don't want long-term. Most over-the-counter "sleep gummies" are underdosed CBD plus melatonin, and the melatonin is usually doing the work. CBT-I still beats both in head-to-head trials.

  2. Hot flashes and night sweats

    Evidence: Weak / mixed

    Despite the marketing, there is no good trial evidence that CBD or THC reduces flash frequency. They can reduce the bother and the secondary insomnia, which is not nothing, but it's a downstream effect rather than a vasomotor mechanism. HRT, SSRIs/SNRIs, gabapentin, fezolinetant and CBT-Meno all have stronger evidence here.

  3. Anxiety

    Evidence: Modest

    CBD has a reasonable signal for acute anxiety at 300–600 mg single doses in trial settings, though daily-use evidence is thinner. THC is the opposite story, low doses can blunt anxiety, higher doses reliably worsen it, and in midlife the dose that flips from calm to panicky often drops.

  4. Pain (joint, musculoskeletal, neuropathic)

    Evidence: Moderate

    This is cannabis's strongest evidence base in midlife. Combined THC:CBD products show meaningful effect for chronic pain and neuropathic pain in systematic reviews, comparable to some prescription analgesics. CBD-only products show a weaker but real signal for inflammatory joint pain. Topicals are mostly placebo unless the formulation is specifically designed for transdermal absorption.

  5. Mood and depression

    Evidence: Weak / mixed

    No good evidence that CBD or THC treats depression. Regular THC use is associated with worse depression and anxiety outcomes over time, especially when it starts as self-medication. If mood is the symptom, the CBT, SSRI and HRT routes have actual evidence behind them.

  6. Libido and sexual response

    Evidence: Anecdotal only

    The category is full of "intimacy oils" and "arousal gummies" with essentially no controlled-trial evidence in menopausal women. Some people report that small THC doses lower anticipatory anxiety and help them be present, which is plausible but not the same as a treatment. For genitourinary symptoms specifically, local vaginal estrogen does the actual physiological work.

The interactions almost nobody flags

CBD and THC go through the same liver enzymes as a lot of your other medications

This is the section the dispensary clerk and the wellness influencer both skip. CBD in particular is a meaningful inhibitor of the CYP450 enzymes (mainly CYP3A4 and CYP2C9) that metabolize a long list of common midlife medications. The effects are usually manageable, but they are real and worth knowing about before you start.

  1. HRT (oral estradiol, progesterone)

    CBD inhibits the same CYP3A4 and CYP2C9 liver enzymes that metabolize oral estradiol and oral progesterone, which can raise hormone levels modestly. Transdermal estrogen (patches, gels, sprays) largely bypasses this pathway and is less affected. Worth mentioning, not usually worth stopping HRT over, the conversation belongs in the appointment.

  2. SSRIs and SNRIs

    CBD can raise blood levels of several antidepressants (sertraline, citalopram, venlafaxine) via the same liver enzymes. The practical risk is more side effects, not new dangerous ones, but a dose review is reasonable if you're using daily CBD.

  3. Tamoxifen and aromatase inhibitors

    Tamoxifen needs CYP2D6 and CYP3A4 to become its active form. CBD can blunt that conversion in theory, which matters for anyone using tamoxifen for breast cancer or breast cancer prevention. This is the interaction most worth raising with the oncology team before starting CBD.

  4. Blood thinners (warfarin, apixaban, clopidogrel)

    Well-documented interaction with warfarin specifically, CBD raises INR. With the DOACs the data is thinner but the mechanism is the same. If you're on any anticoagulant, this is a flag-it-first conversation.

  5. Statins, benzodiazepines, some seizure meds

    Same CYP450 story. The clinical effect varies by drug and dose. A pharmacist is often the fastest way to get a clean read on your specific list.

Legality and quality, briefly

One paragraph, not a lecture

Legal status varies enormously, by country, by US state, by province, by whether a product crosses a border, and by whether you drive afterwards. Assume nothing transfers. On quality, the floor is a recent certificate of analysis (COA) from a third-party lab, showing the actual CBD and THC content and screening for pesticides, heavy metals and solvents. Reputable brands publish them per batch. The category is otherwise lightly regulated, and a lot of product labels overstate the dose.

How to raise this at the appointment

What to ask, in plain words

  • If you're starting: "I'm thinking about trying CBD for [sleep / joint pain / anxiety]. Given my current medications, is there anything you'd want me to know about interactions or dose?"
  • If you're already using it: "I want to add this to my chart. I take [product, dose, how often]. Does anything on my medication list need a second look?"
  • If you're on tamoxifen or a blood thinner: "Before I try anything cannabis-based, can we talk through whether that's a workable plan with what I'm already on?"
  • If THC is on the table where you live: "I'd like to understand the dose I should start at, given my age and what I'm already taking, rather than guessing."